New hope for Tough-to-Treat blood cancer: drug combo trial shows promise
NCT ID NCT04182204
Summary
This study tested whether adding a targeted drug called polatuzumab vedotin to a standard chemotherapy combination (R-GemOx) could help people with an aggressive type of lymphoma that had come back or stopped responding to prior treatments. It involved 270 adults whose cancer had relapsed or was refractory. The main goal was to see if the new combination helped patients live longer compared to the standard treatment alone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Abdurrahman Yurtarslan Onkoloji Training and Research Hospital
Ankara, 06200, Turkey (Türkiye)
-
Akdeniz Uni School of Medicine
Antalya, 07059, Turkey (Türkiye)
-
All India Institute of Medical Sciences ,Institute Rotary Cancer Hospital
New Delhi, National Capital Territory of Delhi, 110029, India
-
Amerikan HAstanesi Onkoloji Birimi Te?vikiye
Ni?anta??, 34365, Turkey (Türkiye)
-
Attiko Hospital
Athens, 124 62, Greece
-
Az. Osp. Uni Ria Policlinico Tor Vergata
Rome, Lazio, 00133, Italy
-
Azienda Ospedaliero-Universitaria Policlinico di Modena Ematologia
Modena, Emilia-Romagna, 41123, Italy
-
Cancer Center, Sun Yat-sen University of Medical Sciences
Guangzhou, 510060, China
-
Cancer Specialists
Jacksonville, Florida, 32256, United States
-
Centre Henri Becquerel
Rouen, 76038, France
-
Centre hospitalier regional de Trois-Rivieres
Trois-Rivières, Quebec, G8Z 3R9, Canada
-
Chungnam National University Hospital
Daejeon, 35015, South Korea
-
First Affiliated Hospital of Medical College of Xi'an Jiaotong University
Xi'an, 710061, China
-
Guangxi Cancer Hospital of Guangxi Medical University
Nanning, 530021, China
-
Gyeongsang National University Hospital
Gyeongsangnam-do, 52727, South Korea
-
Health Pharma Professional Research
Mexico City, Mexico CITY (federal District), 03100, Mexico
-
Hopital Bretonneau
Tours, 37044, France
-
Hopital De Haut Leveque
Pessac, 33604, France
-
Hopital Henri Mondor
Créteil, 94010, France
-
Hospital Clinico Universitario de Salamanca
Salamanca, 37007, Spain
-
Hospital Sao Rafael - HSR
Salvador, Estado de Bahia, 41253-190, Brazil
-
Hospital Univ. 12 de Octubre
Madrid, 28041, Spain
-
Hospital Universitari Germans Trias i Pujol
Badalona, Barcelona, 08915, Spain
-
Hospital Universitario Dr. Peset
Valencia, 46017, Spain
-
Hospital Universitario de Canarias
San Cristóbal de La Laguna, Tenerife, 38320, Spain
-
Hospital das Clinicas - FMUSP
São Paulo, São Paulo, 05403-000, Brazil
-
Hospital das Clinicas - UFRGS
Porto Alegre, Rio Grande do Sul, DUMMY_VALUE, Brazil
-
Hospital de Especialidades Centro Medico Nacional La Raza
Mexico City, Mexico CITY (federal District), 02990, Mexico
-
Hu Nan Provincial Cancer Hospital
Changsha, 410006, China
-
ICANS
Strasbourg, 67200, France
-
IHA Hematology Oncology Consultants - Ann Arbor
Ann Arbor, Michigan, 48106, United States
-
Institute of Hematology and Hospital of Blood Disease
Tianjin, 300020, China
-
Instituto Nacional de Cancerologia
Distrito Federal, 14080, Mexico
-
Istanbul Uni Istanbul Medical Faculty
Istanbul, 34093, Turkey (Türkiye)
-
Istanbul University Cerrahpasa Medical Faculty
Istanbul, 34098, Turkey (Türkiye)
-
Kings College Hospital
London, SE5 9RS, United Kingdom
-
Kocaeli Universitesi Tip Fakultesi
Kocaeli, 41380, Turkey (Türkiye)
-
Laiko General Hospital
Athens, 115 27, Greece
-
Liga Norte Riograndense Contra O Câncer
Natal, Rio Grande do Norte, 59040150, Brazil
-
London Health Sciences Centre
London, Ontario, N6A 5W9, Canada
-
MSKCC at Basking Ridge
Basking Ridge, New Jersey, 07920, United States
-
Memorial Cancer Institute at Memorial West
Pembroke Pines, Florida, 33028, United States
-
Memorial Sloan Kettering Cancer Center at Bergen
Montvale, New Jersey, 07645, United States
-
Memorial Sloan Kettering Nassau
Uniondale, New York, 11553, United States
-
Memorial Sloan-Kettering Cancer Center
New York, New York, 10065, United States
-
Niagara Health Systems - St. Catherines General Site
St. Catharines, Ontario, L2R 7C6, Canada
-
Nottingham City Hospital
Nottingham, NG5 1PB, United Kingdom
-
Oulu University Hospital
Oulu, 90029, Finland
-
Pusan National University Hospital
Busan, 49241, South Korea
-
Sakarya Universitesi Egitim ve Arastirma Hastanesi
Adapazari/Sakarya, 54100, Turkey (Türkiye)
-
Seoul National University Bundang Hospital
Seongnam-si, 13605, South Korea
-
Severance Hospital, Yonsei University Health System
Seoul, 03722, South Korea
-
St James' Hospital
Dublin, DUMMY_VALUE, Ireland
-
Tampere University Hospital
Tampere, 33520, Finland
-
Tata Medical Center
Kolkata, West Bengal, 700160, India
-
Tata Memorial Hospital
Mumbai, Maharashtra, 400013, India
-
The 1st Affiliated Hospital of Nanchang Unversity
Nanchang, 330006, China
-
USL 4 di Prato - Nuovo Ospeale di Prato
Prato, Tuscany, 59100, Italy
-
Uni Degli Studi Di Bari, Policlinico
Bari, Apulia, 70124, Italy
-
Union Hospital Tongji Medical College Huazhong University of Science and Technology
Wuhan, 430023, China
-
Universitätsklinikum Ulm
Ulm, 89081, Germany
-
West China Hospital - Sichuan University
Chengdu, 610047, China
Conditions
Explore the condition pages connected to this study.